Fennec (FENC) Gets CRL From FDA for Pedmark, Stock Down

Published on November 30, 2021

Fennec (FENC) suffers a setback again with a CRL for its new drug application (NDA) for Pedmark. Shares are down in pre-market trading.

Continue reading on website
Other news

Best Penny Stocks To Buy Now For A Short Squeeze? 5 To Watch

November 30, 2021
Looking for short squeeze penny stocks? Give these 5 a look.

Northern Trust (NTRS) Fortifies Relationship With Pendal

November 30, 2021
Northern Trust (NTRS) tightens its partnership ties with Pendal, which will likely drive its top line and strengthen its position on the competitive landscape.